Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

BioStock: CLS starts new clinical study in prostate cancer

Clinical Laserthermia Systems

Clinical Laserthermia Systems is in the midst of launching the TRANBERG Thermal Therapy System for minimally invasive image-guided focal laser ablation. Now, U.S. based HALO Precision Diagnostics  has shown interest in testing the system. The two companies are starting a study  in patients with prostate cancer, with the aim of starting to use it in some of HALO's 16 clinics.

Read the article at biostock.se:

https://www.biostock.se/en/2023/11/cls-starts-new-clinical-study-in-prostate-cancer/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.